To evaluate visual outcomes and patient satisfactory after PanOptix implantation in hyperopic cataract patients
Patients with axial length ≤22.5mm will be recruited. The subjects will undergo bilateral uneventful phacoemulsification and implantation of PanOptix. Visual quality and patients satisfactory will be assessed three months after the surgery.
Study Type
OBSERVATIONAL
Enrollment
44
Best corrected distance visual acuity of the operated eye
Best corrected distance visual acuity (BCDVA) of the operated eye will be measured.
Time frame: 3 months postoperatively
Uncorrected distance visual acuity (UCVA)
Uncorrected distance visual acuity (UCVA) of the operated eye will be measured at 5m.
Time frame: 3 months postoperatively
Uncorrected intermediate visual acuity
Uncorrected intermediate visual acuity of the operated eye will be measured at 60cm and 80cm respectively.
Time frame: 3 months postoperatively
Uncorrected near visual acuity
Uncorrected near visual acuity of the operated eye will be measured at 40cm.
Time frame: 3 months postoperatively
Best corrected intermediate visual acuity
Best corrected intermediate visual acuity of the operated eye will be measured at 60cm and 80cm respectively.
Time frame: 3 months postoperatively
Best corrected near visual acuity
Best corrected near visual acuity of the operated eye will be measured at 40cm.
Time frame: 3 months postoperatively
Manifest refraction spherical equivalent
Manifest refraction spherical equivalent of the operated eye will be measured
Time frame: 3 months postoperatively
Visual disturbance, spectacle independence and patient satisfaction
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
A questionnaire including visual disturbance, spectacle independence and patient satisfaction will be distributed to subjects.
Time frame: 3 months postoperatively